{"schema_version":"secwatch.filing_event.v1","accession":"0001091818-24-000056","form_type":"8-K","ticker":"BFNH","cik":"0001310488","company_name":"BIOFORCE NANOSCIENCES HOLDINGS, INC.","filed_at":"2024-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.791023+00:00","generated_at":"2026-06-02T16:42:14.102018+00:00","sec_items":["4.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"BioForce Nanosciences replaces auditor BF Borgers with Michael Gillespie & Associates","bullets":["Effective May 7, 2024, BioForce Nanosciences dismissed BF Borgers CPA PC as its independent auditor and retained Michael Gillespie & Associates, PLLC.","BF Borgers' audit reports for FY 2022 and 2023 contained no adverse opinion, qualification, or modification.","No disagreements or reportable events occurred between the company and BF Borgers during the covered periods."],"urls":{"canonical":"https://secwatch.observer/filing/0001091818-24-000056","json":"https://secwatch.observer/filing/0001091818-24-000056.json","markdown":"https://secwatch.observer/filing/0001091818-24-000056.md","text":"https://secwatch.observer/filing/0001091818-24-000056.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1310488/000109181824000056/0001091818-24-000056-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1310488/000109181824000056/bfnh0705248k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T16:42:14.102018+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"280a3aebbc8ee865abe272e1f18219acec29f4a8","claim":"BIOFORCE NANOSCIENCES HOLDINGS, INC. dismissed BF Borgers CPA PC as its auditor.","evidence_excerpt":"Effective May 7, 2024, BioForce NanoSciences Holdings, Inc. (the “Company) replaced BF Borgers CPA PC (“BF Borgers”) as its independent registered public accounting firm.","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1310488/000109181824000056/0001091818-24-000056-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"dismissal"},{"label":"Auditor","value":"BF Borgers CPA PC"},{"label":"Successor","value":"Michael Gillespie & Associates, PLLC"}]},{"claim_id":"dbeb56da84437912d33d760335573e66a6749fc8","claim":"BIOFORCE NANOSCIENCES HOLDINGS, INC. engaged Michael Gillespie & Associates, PLLC as its auditor.","evidence_excerpt":"The Company has retained Michael Gillespie & Associates, PLLC as its new auditing firm.","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1310488/000109181824000056/0001091818-24-000056-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"engagement"},{"label":"Auditor","value":"Michael Gillespie & Associates, PLLC"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}